We are excited to introduce our new video series “Inside Innovation: Micro Talks with the CEO”, launching today on our social media channels. In this insightful series, our Founder & Chief Executive Officer, Professor Jarosław Dastych, will discuss the most significant topics about our company. From the world of phages and our innovative solutions to advanced production and research facilities in Poland and India, each video offers brief yet full of impactful discussions on Proteon’s latest developments and future plans.
Follow us on LinkedIn for more updates and links to the videos!
Video Series Overview:
- Our Technology: In the first video Professor Jarosław Dastych explores the unique features and capabilities of Proteon’s technological platform and its advantages in developing phage-based products. Additionally, discover our strategies for tackling global market challenges and advancing the field of biotechnology.
- Bacteriophages: In this next interview, the CEO of Proteon Pharmaceuticals, Professor Dastych, discusses the motivation behind the company’s pioneering focus on bacteriophage research. He explains how phages can tackle the growing problem of antimicrobial resistance (AMR). Professor Dastych also shares details about the safety protocols and thorough testing procedures that ensure the safety and effectiveness of Proteon’s phage-based products.
- Research & Development: In this video, our CEO presents the recently opened, Proteon’s state-of-the-art laboratories, equipped with modern infrastructure and technology. Our highly qualified team of scientists is engaged in pioneering studies here. Professor Dastych will highlight the centre’s objectives, its potential impact on bacteriophage research, and provide insights into the projects currently under development.
- Supporting the UN Sustainable Development Goals (SDGs): In this part, Professor Jarosław Dastych highlights our commitment to the Sustainable Development Goals, a set of global objectives established by the United Nations to address pressing challenges such as health and environmental sustainability by 2030. Our innovative phage-based solutions promote sustainable food production, address antimicrobial resistance, enhance health and well-being, and foster partnerships for sustainable development. Through these efforts, we contribute to global sustainability and the advancement of biotechnology.
- Future Products & Solutions: In the latest video, Professor Jarosław Dastych shares insights into the future of bacteriophage-based products at Proteon. This episode highlights the upcoming bacteriophage-based advancements that our R&D team is developing and their potential to foster improvements in the animal welfare. Our products align with our mission to create a safer, more sustainable world through cutting-edge biotechnology.
- Combatting Antimicrobial Resistance: Professor Dastych discusses our innovative approaches to developing phage-based solutions and the new opportunities this creates for overcoming this critical global challenge – the antimicrobial resistance crisis. Discover how our research is at the forefront of more effective treatments, contributing to a healthier future.
- Proteon’s Pipeline: Upcoming Bacteriophage Solutions: In the final episode of “Micro Talks with the CEO,” Professor Jarosław Dastych shares Proteon Pharmaceuticals’ future products pipeline. Discover our upcoming bacteriophage-based solutions, including advancements for poultry, swine, and dairy cows, as well as projects in environmental remediation.
Don’t miss this insightful look into how Proteon is advancing the field of bacteriophage research. The next video is scheduled for release at the beginning of December 2024. Stay tuned for more updates!
